William S. Powell
1001 Decarie Blvd
Montreal, QC H4A3J1, Canada
Montreal, QC H4A3J1, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Concise Syntheses of Microsomal Metabolites of a Potent OXE (Oxoeicosanoid) Receptor Antagonist.
Journal: Chemical & pharmaceutical bulletin
Published: July 02, 2023
Metabolism of anti-inflammatory OXE (oxoeicosanoid) receptor antagonists by nonhuman primates.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: September 30, 2021
Targeting the OXE receptor with a selective antagonist inhibits allergen-induced pulmonary inflammation in non-human primates.
Journal: British journal of pharmacology
Published: April 19, 2021
Eicosanoid receptors as therapeutic targets for asthma.
Journal: Clinical science (London, England : 1979)
Published: January 18, 2021
Protein kinase C activates NAD kinase in human neutrophils.
Journal: Free radical biology & medicine
Published: May 23, 2020
Targeting the OXE receptor as a potential novel therapy for asthma.
Journal: Biochemical pharmacology
Published: February 17, 2020
Inhibition of allergen-induced dermal eosinophilia by an oxoeicosanoid receptor antagonist in non-human primates.
Journal: British journal of pharmacology
Published: May 03, 2019
Novel highly potent OXE receptor antagonists with prolonged plasma lifetimes that are converted to active metabolites in vivo in monkeys.
Journal: British journal of pharmacology
Published: February 01, 2019
Leukotriene B4-type I interferon axis regulates macrophage-mediated disease tolerance to influenza infection.
Journal: Nature microbiology
Published: October 12, 2018
Tolerogenic signaling of alveolar macrophages induces lung adaptation to oxidative injury.
Journal: The Journal of allergy and clinical immunology
Published: July 19, 2018
Novel Highly Potent and Metabolically Resistant Oxoeicosanoid (OXE) Receptor Antagonists That Block the Actions of the Granulocyte Chemoattractant 5-Oxo-6,8,11,14-Eicosatetraenoic Acid (5-oxo-ETE).
Journal: Journal of medicinal chemistry
Published: July 05, 2018
Corrigendum to "In vivo α-hydroxylation of a 2-alkylindole antagonist of the OXE receptor for the eosinophil chemoattractant 5-oxo-6,8,11,14-eicosatetraenoic acid in monkeys" [Biochem. Pharmacol. 138 (2017) 107-118].
Journal: Biochemical pharmacology
Published: May 14, 2018
Last Updated: 09/26/2026